drugset / Trial / NCT00828477
Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)
Non-randomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to evaluate and compare the comfort of bromfenac or nepafenac following SLT.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bromfenac | Other / unclassified | 0.09 % | Topical |
| Comparator | Nepafenac | Other / unclassified | 0.1 % | Topical |
Indications
No indication recorded.